Skip to main content

FOSRENOL lanthanum 750 mg (as lanthanum carbonate hydrate) chewable tablet bottle, Shire Australia Pty Limited, CON-231

Product name
FOSRENOL lanthanum 750 mg (as lanthanum carbonate hydrate) chewable tablet bottle
Sponsor name
Shire Australia Pty Limited
Consent start
Consent no.
CON-231
Standard
Subclause 3(2)(l) of the Therapeutic Goods Order No.69 '“ General requirements for the labels for medicines
Non-compliance with standard
The product labels do not bear the current sponsor's address.
Conditions imposed
    The labels to which this consent applies are those previously approved for the former address Level 6, 123 Epping Road, North Ryde NSW 2113. Arrangements are in place for the prompt referral of any queries or complaints concerning the products to the current address (Level 39, 225 George Street, Sydney NSW 2000).  
Therapeutic product type
Prescription medicines

Help us improve the Therapeutic Goods Administration site